Precision Polyolefins (PPL) utilizes proprietary catalyst technology to produce xPAOs Ã¢â‚¬â€œ a revolutionary new class of reactive polymer that will be used by PPL and its customers to create a new landscape of performance enhancing additives for advanced materials, including superior coatings, lubricants, and phase change materials for thermal regulation.
Primary Application Area: Materials, Chemical
Technology Development Status: Proven Manufacturability
FIGURES OF MERIT
Value Proposition: xPAO functional polyolefins fill a major gap in the market for more specialized polyolefins with tailored properties that can meet challenging technological requirements associated with higher-value applications. The significant value of xPAO derived additives to formulators of lubricant and coating products will be realized through higher performance and differentiated products.
xPAOs are produced using a drop-in ready technology that has been validated on the pilot scale and are derived from the same inexpensive commodity olefin precursors as the existing limited palate of molecularly ill-defined commodity polyolefins, allowing economic production on any scale commensurate with market demands.
PPL represents a new business model within the polyolefins industry. Specifically, PPL is the first company that can use its proprietary technology to custom-tailor polyolefins for a variety of high value applications that large commodity producers of polyolefins cannot service due to the significant difference in the economy of scales. PPL can be viewed as being the first ‘craft’ producer of specialty polyolefins that possess best-in-class performance metrics for a variety of end-use applications.
Organization Type: Mid-stage Startup (A or B)
Showcase Booth #: 30M
GOVT/EXTERNAL FUNDING SOURCES
SBIR/STTR Awards: $150,000 SBIR Phase I, NSF, Start date 1/1/14
$30,000 SBIR Phase IB, NSF, Start date 1/7/14
$750,000 SBIR Phase II, NSF, Start date 9/15/15
External Funding to Date: Founder investment
Corporate SBIR Phase IB matching
Corporate licensing agreement
Corporate sponsored research agreement (over 3 years)